Medicare Enrolled

Dr. Halim Fadil, M.D.

Neurology · Arlington, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
801 ROAD TO SIX FLAGS W STE 127, Arlington, TX 76012
8176978000
In practice since 2007 (18 years)
NPI: 1982814570 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fadil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fadil? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fadil

Dr. Halim Fadil is a neurology in Arlington, TX, with 18 years in practice. Based on federal Medicare data, Dr. Fadil performed 2,793 Medicare services across 598 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fadil received a total of $11,281 from 61 pharmaceutical and/or device companies across 523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fadil is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 16% volume in TX$ $11,281 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,793
Medicare services
Top 16% in TX for neurology
598
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~155 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, rimabotulinumtoxinb, 100 units1,950$10$18
Office visit, established patient (30-39 min)402$90$211
New patient office visit (45-59 min)134$119$323
Needle measurement of electrical activity in arm or leg muscles, complete study56$77$184
Office visit, established patient (20-29 min)56$61$143
Needle measurement of electrical activity in arm or leg muscles, limited study47$49$121
Office visit, established patient, complex (40-54 min)39$132$285
New patient office visit, complex (60-74 min)34$164$406
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional23$36$104
Nerve conduction, 7-8 studies20$125$408
Nerve conduction, 5-6 studies17$103$293
Initial hospital admission, moderate complexity15$95$216
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,281
Total received (2018-2024)
Avg $1,612/year across 7 years
Top 26% in TX for neurology
61
Companies
523
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,219 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,016
2023
$1,577
2022
$2,343
2021
$2,241
2020
$1,449
2019
$1,264
2018
$390

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sunovion Pharmaceuticals Inc.
$1,116
Teva Pharmaceuticals USA, Inc.
$915
ACADIA Pharmaceuticals Inc
$823
Biogen, Inc.
$643
UCB, Inc.
$570
Neurocrine Biosciences, Inc.
$437
ABBVIE INC.
$424
Kyowa Kirin, Inc.
$377
Amneal Pharmaceuticals LLC
$376
Adamas Pharmaceuticals, Inc.
$374
Boston Scientific Corporation
$305
Acorda Therapeutics, Inc
$301
Lilly USA, LLC
$265
Amgen Inc.
$259
AbbVie Inc.
$236
Lundbeck LLC
$231
SK Life Science, Inc.
$226
MDD US Operations, LLC
$214
Novartis Pharmaceuticals Corporation
$199
AbbVie, Inc.
$198
EMD Serono, Inc.
$193
Supernus Pharmaceuticals, Inc.
$171
ARGENX US, INC.
$166
Allergan, Inc.
$165
Abbott Laboratories
$159
Avion Pharmaceuticals
$131
PFIZER INC.
$112
UPSHER-SMITH LABORATORIES LLC
$105
Vanda Pharmaceuticals Inc.
$100
Alexion Pharmaceuticals, Inc.
$98
GE HEALTHCARE
$98
US WorldMeds, LLC
$92
MERZ NORTH AMERICA, INC.
$90
GE HealthCare
$78
Horizon Therapeutics plc
$75
Biohaven Pharmaceuticals, Inc.
$74
Celgene Corporation
$66
Xeris Pharmaceuticals, Inc.
$65
Biohaven Pharmaceutical Holding Company Ltd.
$62
Janssen Pharmaceuticals, Inc
$61
REVANCE THERAPEUTICS, INC.
$56
Ipsen Biopharmaceuticals, Inc
$53
Neurelis, Inc.
$51
Vertical Pharmaceuticals, LLC
$50
Avanir Pharmaceuticals, Inc.
$42
Medtronic USA, Inc.
$41
Collegium Pharmaceutical, Inc.
$33
Genentech USA, Inc.
$32
Allergan Inc.
$31
Octapharma USA, Inc.
$29
AstraZeneca Pharmaceuticals LP
$25
Eisai Inc.
$25
GE Healthcare
$23
Nevro Corp.
$21
Corium, LLC
$20
Sumitomo Pharma America, Inc.
$18
Arbor Pharmaceuticals, Inc.
$18
Azurity Pharmaceuticals, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$17
IMPEL PHARMACEUTICALS INC.
$15
SCILEX PHARMACEUTICALS INC.
$15
Top 3 companies account for 25.3% of total payments
Associated products mentioned in payments ›
ACTIVA · ADLARITY · ADUHELM · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · Briviact · CREXONT · DAXXIFY · DIVIGEL · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - celecoxib · EMGALITY · GENERAL DBS · GENERAL - DBS · GILENYA · GOCOVRI · Gocovri · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · Leqembi · MYOBLOC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · Ongentys · PANZYGA · PLEGRIDY · PONVORY · Ponvory · QULIPTA · REXULTI · RYTARY · Rebif · SKYCLARYS · SOLIRIS · Senza · Soliris · TECFIDERA · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · XEOMIN · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $404 per 100 Medicare services performed
Looking for a neurology in Arlington?
Compare neurologys in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
209
Per 100K population
9.8
County median income
$81,905
Nearest hospital
TEXAS HEALTH ARLINGTON MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fadil is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Fadil experienced with injection, rimabotulinumtoxinb, 100 units?
Based on Medicare claims data, Dr. Fadil performed 1,950 injection, rimabotulinumtoxinb, 100 units services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fadil receive payments from pharmaceutical companies?
Yes. Dr. Fadil received a total of $11,281 from 61 companies across 523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fadil's costs compare to other neurologys in Arlington?
Dr. Fadil's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fadil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →